BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8695215)

  • 1. Quality of prostate cancer data in the cancer registry of Norway.
    Harvei S; Tretli S; Langmark F
    Eur J Cancer; 1996 Jan; 32A(1):104-10. PubMed ID: 8695215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completeness and accuracy of registration of ovarian cancer in the cancer registry of Norway.
    Tingulstad S; Halvorsen T; Norstein J; Hagen B; Skjeldestad FE
    Int J Cancer; 2002 Apr; 98(6):907-11. PubMed ID: 11948471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completeness of invasive cervical cancer at the Cancer Registry of Norway.
    Bilet EF; Langseth H; Thoresen SØ; Bray F
    Acta Oncol; 2009; 48(7):1070-3. PubMed ID: 19353339
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality of data reported on abdominal aortic aneurysm repair--a comparison between a national vascular and a national administrative registry.
    Haug ES; Romundstad P; Saether OD; Jørgenvåg R; Myhre HO
    Eur J Vasc Endovasc Surg; 2005 Jun; 29(6):571-8. PubMed ID: 15878531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prostate cancer mortality in Norway: influence of Cancer Registry information?
    Hernes E; Harvei S; Glattre E; Gjertsen F; Fosså SD
    APMIS; 2005; 113(7-8):542-9. PubMed ID: 16086825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway.
    Bakken IJ; Gystad SO; Christensen ØO; Huse UE; Larønningen S; Nygård J; Holmstrøm L; Johannesen TB; Møller B; Larsen IK
    Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1336-40. PubMed ID: 22717858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The completeness and accuracy of the Norwegian Female Incontinence Registry.
    Dyrkorn OA; Staff AC; Kulseng-Hanssen S; Dimoski T; Svenningsen R
    Acta Obstet Gynecol Scand; 2020 Dec; 99(12):1618-1625. PubMed ID: 32640493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness.
    Larsen IK; Småstuen M; Johannesen TB; Langmark F; Parkin DM; Bray F; Møller B
    Eur J Cancer; 2009 May; 45(7):1218-1231. PubMed ID: 19091545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low proportion of unreported cervical treatments in the cancer registry of Norway between 1998 and 2013.
    Leinonen MK; Hansen SA; Skare GB; Skaaret IB; Silva M; Johannesen TB; Nygård M
    Acta Oncol; 2018 Dec; 57(12):1663-1670. PubMed ID: 30169991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Norwegian prostate cancer mortality: evidence of over-reporting.
    Löffeler S; Halland A; Weedon-Fekjær H; Nikitenko A; Ellingsen CL; Haug ES
    Scand J Urol; 2018 Apr; 52(2):122-128. PubMed ID: 29325479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness.
    Bray F; Parkin DM
    Eur J Cancer; 2009 Mar; 45(5):747-55. PubMed ID: 19117750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prostate cancer mortality in Norway evaluated by automated classification of medical entities.
    Hernes E; Johansson LA; Fosså SD; Pedersen AG; Glattre E
    Eur J Cancer Prev; 2008 Aug; 17(4):331-5. PubMed ID: 18562957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records.
    Desai MM; Bruce ML; Desai RA; Druss BG
    Am J Epidemiol; 2001 Feb; 153(3):299-306. PubMed ID: 11157418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of data quality in the National Prostate Cancer Register of Sweden.
    Tomic K; Sandin F; Wigertz A; Robinson D; Lambe M; Stattin P
    Eur J Cancer; 2015 Jan; 51(1):101-11. PubMed ID: 25465187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is registration of multiple myeloma in the Norwegian Cancer Registry good enough?].
    Aasbrenn M; Langmark F; Wisløff F
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2712-4. PubMed ID: 19079417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of completeness of registration at the Estonian cancer registry.
    Lang K; Mägi M; Aareleid T
    Eur J Cancer Prev; 2003 Apr; 12(2):153-6. PubMed ID: 12671539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Swedish Colorectal Cancer Registry: an overview of completeness, timeliness, comparability and validity.
    Moberger P; Sköldberg F; Birgisson H
    Acta Oncol; 2018 Dec; 57(12):1611-1621. PubMed ID: 30477372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Central nervous system tumours in children. An evaluation of the completeness and validity of the Cancer Registry].
    Thorsteinsson R; Sørensen M; Jensen TL; Bernhardtsen TM; Gjerris F; Carstensen H; Schmiegelow K; Raaschou-Nielsen O
    Ugeskr Laeger; 2005 Oct; 167(40):3782-5. PubMed ID: 16221395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the concordance of trauma registry data and hospital records.
    McKenzie K; Walker S; Besenyei A; Aitken LM; Allison B
    Health Inf Manag; 2005; 34(1):3-7. PubMed ID: 18239222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.